Inventor · disambiguated record
David Bancroft
Also filed as: BANCROFT DAVID
3 granted patents·5 pending applications·39 citations·filing 2000–2024
65Inventor score
Files withIOMX THERAPEUTICS AG5CYTENA GMBH1MAX PLANCK GES ZUR FORDERUNGDE1MAX PLANCK GES ZUR FURDERUNG D1
Top patents by PatentIndex Score
8 records- 0186US6664048B1Identification and characterization of interacting moleculesMAX PLANCK GES ZUR FURDERUNG D·Filed 2000·Granted Dec 16, 2003·36 cites·47 claims
- 0271US2025084076A1Heterocyclic kinase inhibitors and uses thereofIOMX THERAPEUTICS AG·Filed 2024·Application pending·0 cites
- 0371US2025101015A1Heterocyclic kinase inhibitors and uses thereofIOMX THERAPEUTICS AG·Filed 2024·Application pending·0 cites
- 0451US12172993B2Heterocyclic kinase inhibitors and uses thereofIOMX THERAPEUTICS AG·Filed 2019·Granted Dec 24, 2024·0 cites·53 claims
- 0550US6905818B1Method for the identification and characterization of interacting molecules by automated interaction matingMAX PLANCK GES ZUR FORDERUNGDE·Filed 2000·Granted Jun 14, 2005·3 cites·76 claims
- 0647US2023192701A1Bicyclic kinase inhibitors and uses thereofIOMX THERAPEUTICS AG·Filed 2021·Application pending·0 cites
- 0744US2023348453A1Halogenated-heteroaryl and other heterocyclic kinase inhibitors, and uses thereofIOMX THERAPEUTICS AG·Filed 2021·Application pending·0 cites
- 0839US2021139832A1Method for producing at least one closed region on a carrier surface of a carrierCYTENA GMBH·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Bancroft files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →